[ET Net News Agency, 8 November 2024] EVEREST MED-B (01952) rose 10% to HK$35.75.
It hits an intra-day high of HK$35.95, and an intra-day low of HK$32.8. The total shares
traded was 4.74 million, with a value of HK$162.98m. The active buy/sell ratio is 69:31,
with net buying turnover of HK$60.72m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$2.27m, with volume weighted average price of HK$34.81.
CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of
HK$14.06m, with volume weighted average price of HK$34.026. The stock has risen a combined
10.5% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 35.750 % Chg +10.00%
High 35.950 Low 32.800
Shares Tr 4.74m Turnover 162.98m
10-D SMA 32.470 %H.V 101.030
20-D SMA 30.475 VWAP 34.403
50-D SMA 26.547 RSI14 66.964
----------------------------------
Status: Active buy/sell ratio is 69:31, with net buying turnover of HK$60.72m, rising a
combined 10.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 35.75 +10.00
GENSCRIPT BIO (01548) 10.96 -6.16
INNOVENT BIO (01801) 39.05 +4.27
JXR (01951) 3.54 -1.39
WUXI BIO (02269) 17.28 -1.48
WUXI APPTEC (02359) 57.20 -1.12
BEIGENE (06160) 123.10 +1.07
CANSINOBIO (06185) 31.00 +7.83
ASCENTAGE-B (06855) 43.85 -0.34
AKESO (09926) 68.85 +3.77
---------------------------------------------
(ed)